<DOC>
	<DOCNO>NCT02667093</DOCNO>
	<brief_summary>The purpose project develop process identify highly personalize antigen uniquely express patient 's leukemia cell use cellular immune therapy .</brief_summary>
	<brief_title>Samples From Leukemia Patients Their Donors Identify Specific Antigens</brief_title>
	<detailed_description>It well know tumor cell leukemia cell express different surface structure ( call antigen ) serve target cancer cell destruction immune system . Effective immune therapy characterize high specificity low toxicity . One major obstacle impede use therapy standard care identification good target antigen . In acute myeloid leukemia ( AML ) major patient patient variation leukemia antigen , universal AML cell target . Rather , patient unique array potential cell target . Thanks rapid progress new DNA/RNA sequencing technology , identification unique , patient-specific leukemia cell antigen-targets possible . The purpose project develop process identify highly personalize antigen uniquely express patient 's leukemia cell use cellular immune therapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>Diagnosis Leukemia plan receive bone marrow transplant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acute Leukemia</keyword>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>AML</keyword>
</DOC>